Vaccines for Children Program Has Increased Coverage, but Gaps Remain
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 14, 2024 -- The Vaccines for Children (VFC) program, which provides recommended vaccines at no cost to eligible children, has increased childhood vaccination coverage, but coverage is still lower than among non-VFC-eligible children, according to a Vital Signs report published Aug. 13 in the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Madeleine R. Valier, M.P.H., from the CDC in Atlanta, and colleagues analyzed data from the 2012 to 2022 National Immunization Survey-Child to assess trends in vaccination coverage with one or more doses of the measles, mumps, and rubella vaccine (MMR), two to three doses of the rotavirus vaccine, and a combined seven-vaccine series by VFC program eligibility status.
About 52.2 percent of U.S. children were VFC-eligible. The researchers found that for VFC-eligible children born during 2011 to 2020, by 24 months, coverage was stable for at least one MMR dose (88.0 to 89.9 percent) and for the combined seven-vaccine series (61.4 to 65.3 percent). By age 8 months, rotavirus vaccination coverage was 64.8 to 71.1 percent and increased by an average of 0.7 percent annually. Compared with non-VFC-eligible children, VFC-eligible children had lower coverage for at least one MMR dose, two to three doses of rotavirus vaccine, and the combined seven-vaccine series (3.8, 11.5, and 13.8 percentage points lower, respectively) among all children born in 2020.
"The data presented in this report demonstrate long-term program results for multiple birth cohorts of children," the authors write. "As new vaccines are added and immunization schedules become increasingly complex, maintenance and evolution of the VFC program could help sustain and further increase vaccination coverage."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-15 07:15
Read more
- 2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS
- One Dead, 10 Hospitalized in E. Coli Outbreak Linked to McDonald's Quarter Pounders
- Women Can Incur 'Catastrophic' Bills for Out-of-State Abortions, Study Finds
- Avadel Pharmaceuticals Announces FDA Approval of Lumryz (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy
- Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier
- More Than Half of Heat Deaths Can Be Blamed on Global Warming: Study
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions